134 related articles for article (PubMed ID: 34904763)
21. [In vivo-efficacy of an ear medication using gelatin powder as a vehicle for the therapy of canine otitis externa].
Bouassiba C; Mueller RS
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2017 Aug; 45(4):235-244. PubMed ID: 28594048
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of boric-complexed zinc and acetic-complexed zinc otic preparations for canine yeast otitis externa.
Mendelsohn CL; Griffin CE; Rosenkrantz WS; Brown LD; Boord MJ
J Am Anim Hosp Assoc; 2005; 41(1):12-21. PubMed ID: 15634862
[TBL] [Abstract][Full Text] [Related]
23. Safety and tolerability of 0.1% tacrolimus solution applied to the external ear canals of atopic beagle dogs without otitis.
Kelley LS; Flynn-Lurie AK; House RA; Simpson AC; Marsella R
Vet Dermatol; 2010 Dec; 21(6):554-65. PubMed ID: 20609208
[TBL] [Abstract][Full Text] [Related]
24. Cortisol Concentrations in Well-Regulated Dogs with Hyperadrenocorticism Treated with Trilostane.
Midence JN; Drobatz KJ; Hess RS
J Vet Intern Med; 2015; 29(6):1529-33. PubMed ID: 26374943
[TBL] [Abstract][Full Text] [Related]
25. Topical ear treatment - options, indications and limitations of current therapy.
Paterson S
J Small Anim Pract; 2016 Dec; 57(12):668-678. PubMed ID: 27747880
[TBL] [Abstract][Full Text] [Related]
26. Effect of Intravenous or Perivascular Injection of Synthetic Adrenocorticotropic Hormone on Stimulation Test Results in Dogs.
Johnson CM; Kass PH; Cohen TA; Feldman EC
J Vet Intern Med; 2017 May; 31(3):730-733. PubMed ID: 28407319
[TBL] [Abstract][Full Text] [Related]
27. Comparative safety and efficacy of topical mometasone furoate with other topical corticosteroids.
Spada F; Barnes TM; Greive KA
Australas J Dermatol; 2018 Aug; 59(3):e168-e174. PubMed ID: 29411351
[TBL] [Abstract][Full Text] [Related]
28. Effect of an anti-inflammatory pomegranate otic treatment on the clinical evolution and microbiota profile of dogs with otitis externa.
Puigdemont A; D'Andreano S; Ramió-Lluch L; Cuscó A; Francino O; Brazis P
Vet Dermatol; 2021 Apr; 32(2):158-e37. PubMed ID: 33399257
[TBL] [Abstract][Full Text] [Related]
29. Antibiotic plasma levels in dogs with otitis externa treated routinely with various topical preparations.
Voget M; Armbruster M; Meyer M
Berl Munch Tierarztl Wochenschr; 2012; 125(11-12):441-8. PubMed ID: 23227759
[TBL] [Abstract][Full Text] [Related]
30. Survey of otitis externa in American Cocker Spaniels in Finland.
Kaimio M; Saijonmaa-Koulumies L; Laitinen-Vapaavuori O
Acta Vet Scand; 2017 Feb; 59(1):14. PubMed ID: 28241842
[TBL] [Abstract][Full Text] [Related]
31. Physicochemical properties of otic products for Canine Otitis Externa: comparative analysis of marketed products.
Song Y; Abdella S; Afinjuomo F; Weir EJ; Tan JQE; Hill P; Page SW; Garg S
BMC Vet Res; 2023 Feb; 19(1):39. PubMed ID: 36759841
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of baseline cortisol concentration to monitor efficacy of twice-daily administration of trilostane to dogs with pituitary-dependent hyperadrenocorticism: 22 cases (2008-2012).
Woolcock AD; Bugbee AC; Creevy KE
J Am Vet Med Assoc; 2016 Apr; 248(7):814-21. PubMed ID: 27003023
[TBL] [Abstract][Full Text] [Related]
33. The role of Pityrosporum pachydermatis in otitis externa of dogs: evaluation of a treatment with miconazole.
Gedek B; Brutzel K; Gerlach R; Netzer F; Rocken H; Unger H; Symoens J
Vet Rec; 1979 Feb; 104(7):138-40. PubMed ID: 109986
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of hypochlorous acid as an ear flush in dogs with chronic otitis externa.
Mueller RS; Baumann KN; Boehm T; Dörfelt S; Kasper B; Udraite-Vovk L
Vet Dermatol; 2023 Apr; 34(2):134-141. PubMed ID: 36517454
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of in vitro activity of herbal formula Di Er You and herb Coptis against bacteria isolated from dogs with otitis externa.
Olson JNB; Shiau DS; Ma A
Am J Vet Res; 2023 Sep; 84(9):. PubMed ID: 37491003
[TBL] [Abstract][Full Text] [Related]
36. Dynamic adrenal function testing in eight dogs with hyperadrenocorticism associated with adrenocortical neoplasia.
Norman EJ; Thompson H; Mooney CT
Vet Rec; 1999 May; 144(20):551-4. PubMed ID: 10371012
[TBL] [Abstract][Full Text] [Related]
37. The otic microbiota and mycobiota in a referral population of dogs in eastern USA with otitis externa.
Bradley CW; Lee FF; Rankin SC; Kalan LR; Horwinski J; Morris DO; Grice EA; Cain CL
Vet Dermatol; 2020 Jun; 31(3):225-e49. PubMed ID: 31960536
[TBL] [Abstract][Full Text] [Related]
38. Changes in the ear canal microbiota of dogs with otitis externa.
Kasai T; Fukui Y; Aoki K; Ishii Y; Tateda K
J Appl Microbiol; 2021 Apr; 130(4):1084-1091. PubMed ID: 32979301
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the local and systemic side effects of methylprednisolone aceponate and mometasone furoate applied as ointments with equal antiinflammatory activity.
Kecskés A; Heger-Mahn D; Kuhlmann RK; Lange L
J Am Acad Dermatol; 1993 Oct; 29(4):576-80. PubMed ID: 8408793
[TBL] [Abstract][Full Text] [Related]
40. Effect of functional adrenocortical tumors on plasma cortisol and corticotropin concentrations in dogs.
Feldman EC
J Am Vet Med Assoc; 1981 Apr; 178(8):823-6. PubMed ID: 6268586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
